Cognition Therapeutics, Inc. Share Price & Technical Analysis
CGTX · $1.26 (+0.80%)
Healthcare / Biotechnology
$1.26
+0.80%
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of patho…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
0% return in May, -9% avg return in past 3 year May month.
14% return in 2026, 80% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -21% | 0% | -27% | 63% | 0% | – | – | – | – | – | – | – | 14% |
| 25 | 0% | -29% | 0% | 0% | -50% | 0% | 100% | 300% | -39% | 38% | -6% | -22% | 293% |
| 24 | 28% | -5% | -14% | 0% | 5% | -15% | -41% | -30% | -29% | 0% | -20% | 75% | -46% |
| 23 | -5% | -20% | 18% | -10% | 18% | -18% | -11% | -17% | -12% | -21% | 0% | 73% | -6% |
| 22 | -32% | -33% | -12% | 0% | -7% | -30% | -10% | 0% | -5% | -5% | 94% | -34% | -74% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Uptrend
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mild Cognitive Impairment, as well as geographic atrophy secondary to dry age-related macular degeneration and dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$102.48M
P/E ratio
—
52W high
$3.83
52W low
$0.22
Volume
5,25,202
Beta
1.81
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Cognition Therapeutics, Inc. share price today?
- Cognition Therapeutics, Inc. (CGTX) last traded around $1.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CGTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CGTX. Download the app for real-time alerts.
- How can I analyze Cognition Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.